Načítá se...
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
Background: Immune checkpoint inhibitors (ICIs) emerged as the preferred therapy in advanced lung cancer, understanding the treatment- and immune-related adverse events of these drugs is of great significance for clinical practice. Materials and methods: PubMed, Embase, Cochrane library and major co...
Uloženo v:
| Vydáno v: | Biosci Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Portland Press Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7953488/ https://ncbi.nlm.nih.gov/pubmed/32315071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20192347 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|